Literature DB >> 17113605

Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?

Sylvia Santosa1, Krista A Varady, Suhad AbuMweis, Peter J H Jones.   

Abstract

Cholesterol absorption and synthesis contribute to maintaining cholesterol homeostasis. Several physiological and therapeutic factors affect cholesterol homeostasis, including: genetics, circadian rhythm, body weight, plant sterols, ezetimibe, and statin therapy. The present objective is to determine the main vector, i.e. cholesterol absorption or synthesis, affected by each of these factors, and to examine whether an alteration in one vector is linked to a reciprocal change in the other. Current techniques used to assess cholesterol absorption and synthesis are also reviewed. Review of physiological factors affecting cholesterol metabolism suggest a reciprocal relationship between these two vectors. Carriers of the E2 isoform of apolipoprotein E and ATP binding cassette (ABC) G8 19H (exon 1 mutation) show a decrease in cholesterol absorption accompanied by a corresponding increase in synthesis. Circadian rhythm affects cholesterol synthesis, however, its effect on absorption has yet to be established. Obese subjects show an increase in cholesterol synthesis with a subsequent decrease in cholesterol absorption. Weight loss down regulates cholesterol synthesis, but has little or no effect on absorption. In the case of therapeutic factors, plant sterols and stanols inhibit cholesterol absorption, which results in a compensatory increase in synthesis. Ezetimibe also decreases intestinal absorption, while reciprocally increasing synthesis. Statin therapy down regulates synthesis, which is accompanied by a rise in absorption. These findings suggest that a change in one vector, fairly consistently, results in a compensatory and opposing change in the other. An understanding of this reciprocal relationship between cholesterol absorption and synthesis may allow for the development of more effective interventions for dyslipidemic disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113605     DOI: 10.1016/j.lfs.2006.10.006

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  20 in total

1.  A moderate intake of phytosterols from habitual diet affects cholesterol metabolism.

Authors:  T Sanclemente; I Marques-Lopes; M Fajó-Pascual; M Cofán; E Jarauta; E Ros; J Puzo; A L García-Otín
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

Review 2.  Recent advances in small bowel diseases: Part II.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

3.  Serum lipids, plant sterols, and cholesterol kinetic responses to plant sterol supplementation in phytosterolemia heterozygotes and control individuals.

Authors:  Semone B Myrie; David Mymin; Barbara Triggs-Raine; Peter J H Jones
Journal:  Am J Clin Nutr       Date:  2012-02-29       Impact factor: 7.045

4.  Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.

Authors:  Tomás Zambrano; Nicolás Saavedra; Fernando Lanas; José Caamaño; Luis A Salazar
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

Review 5.  Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.

Authors:  Jose Manuel Izquierdo-Palomares; Jesus Maria Fernandez-Tabera; Maria N Plana; Almudena Añino Alba; Pablo Gómez Álvarez; Inmaculada Fernandez-Esteban; Luis Carlos Saiz; Pilar Martin-Carrillo; Óscar Pinar López
Journal:  Cochrane Database Syst Rev       Date:  2016-11-26

Review 6.  Revisiting Human Cholesterol Synthesis and Absorption: The Reciprocity Paradigm and its Key Regulators.

Authors:  Peter A S Alphonse; Peter J H Jones
Journal:  Lipids       Date:  2015-11-30       Impact factor: 1.880

Review 7.  Drug Therapy of Dyslipidemia in the Elderly.

Authors:  Srikanth Yandrapalli; Shashvat Gupta; Gabriela Andries; Howard A Cooper; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

8.  Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort.

Authors:  Verónica Escurriol; Montserrat Cofán; Concepción Moreno-Iribas; Nerea Larrañaga; Carmen Martínez; Carmen Navarro; Laudina Rodríguez; Carlos A González; Dolores Corella; Emilio Ros
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

9.  The role of Niemann-Pick C1 - Like 1 (NPC1L1) in intestinal sterol absorption.

Authors:  Stephen D Turley
Journal:  J Clin Lipidol       Date:  2008-04       Impact factor: 4.766

10.  Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.

Authors:  Nirupa R Matthan; Michael Pencina; Jane M LaRocque; Paul F Jacques; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2009-05-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.